|
|
| 5-Day | 19,071 |
| 10-Day | 29,383 |
| 30-Day | 30,886 |
| 5-Day | 19,071 |
| 10-Day | 29,383 |
| 30-Day | 30,886 |
| 5-Day | 290,063 |
| 10-Day | 398,155 |
| 30-Day | 413,719 |
| 5-Day | 290,063 |
| 10-Day | 398,155 |
| 30-Day | 413,719 |
Announcements
Dr Reddys Labs: FY14 results on May 13, 2014Dr Reddys Labs
Sentimeter
67% of moneycontrol users recommend selling Dr Reddys Labs. What's your call on Dr Reddys Labs today? Read 4 investor views
| Days | BSE | NSE |
| 30 | 2675.53 | 2675.83 |
| 50 | 2681.98 | 2682.27 |
| 150 | 2539.55 | 2540.02 |
| 200 | 2465.61 | 2466.03 |
Click here to view the Open, High, Low, Close, Volume and Spread data for Dr Reddys Labs
| Consolidated | (Dec '13) | (Sep '13) |
| Net Sales | 3,533.76 | 3,357.45 |
| Other Income | 17.73 | 63.67 |
| PBDIT | 697.54 | 736.01 |
| Net Profit | 451.56 | 690.25 |
| Total Share Capital | 84.90 |
| Net Worth | 7783.40 |
| Total Debt | 1589.10 |
| Net Block | 2387.00 |
| Investments | 2379.20 |
| Net Current Assets | 4183.10 |
| Total Assets | 9372.50 |
| Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
| Sun Pharma | 624.30 | 1.58 | 653.10 | 462.50 | 129,302.76 |
| Dr Reddys Labs | 2556.00 | 0.66 | 2939.80 | 1904.15 | 43,479.83 |
| Lupin | 955.25 | 0.23 | 1012.00 | 685.80 | 42,831.10 |
| Cipla | 400.60 | 0.96 | 450.00 | 375.00 | 32,165.03 |
| GlaxoSmithKline | 2497.40 | -0.43 | 3054.40 | 2225.00 | 21,153.73 |
| More » | |||||
| Dec' 13 | Sep' 13 | Jun' 13 | Mar' 13 | |
| Promoter | 25.52 | 25.52 | 25.53 | 25.56 |
| FII | 33.35 | 32.56 | 32.69 | 29.66 |
| DII | 7.55 | 8.88 | 8.84 | 11.03 |
| Others | 33.58 | 33.04 | 32.94 | 33.75 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
| Scheme | No. of Shares |
| Birla Sun Life Frontline Equity Fund (G) | 386,178 |
| Reliance Pharma Fund (G) | 279,814 |
| HDFC Top 200 Fund (G) | 207,751 |
| Reliance Growth Fund - Retail Plan (G) | 197,873 |
Dr Reddys Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 43,479.83 crore.The company has reported a consolidated sales of Rs 3,533.76 crore and a Net Profit of Rs 451.56 crore for the quarter ended Dec 2013.
The company management includes G V Prasad - Chairman & CEO, Satish Reddy - Vice Chairman & Mng.Director, Anupam Puri - Independent Director, Ashok S Ganguly - Independent Director, Bruce L A Carter - Independent Director, J P Moreau - Independent Director, Kalpana Morparia - Independent Director, Omkar Goswami - Independent Director, Ravi Bhoothalingam - Independent Director, Sridar Iyengar - Independent Director.
It is listed on the BSE with a BSE Code of 500124 and the NSE with an NSE Code of DRREDDY.
Its Registered office is at 8-2-337, Road No. 3,,Banjara Hills Hyderabad,Andhra Pradesh - 500034.
Their Registrars are Bigshare Services Pvt. Ltd.
SET SMS ALERT
